Mapping of RNA accessible sites for antisense experiments with oligonucleotide libraries

被引:155
作者
Ho, SP
Bao, YJ
Lesher, T
Malhotra, R
Ma, LY
Fluharty, SJ
Sakai, RR
机构
[1] DuPont Merck Res Labs, CNS Dept, Wilmington, DE 19880 USA
[2] Univ Penn, Sch Med, Dept Anim Biol & Pharmacol, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Inst Neurol Sci, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA
关键词
antisense; RNA mapping; oligonucleotide libraries; angiotensin type-1 receptor;
D O I
10.1038/nbt0198-59
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Antisense experiments are often complicated by the lack of reliable methods for selecting effective antisense sequences. Chimeric oligodeoxynucleotide (ODN) libraries and ribonuclease H (RNase H) were used to identify regions on the 1253 nucleotide angiotensin type-1 receptor (AT(1)) mRNA that are accessible to hybridization with antisense ODNs, Phosphorothioate antisense ODNs targeted against accessible sites reduced AT(1) receptor levels by at least 50% in cell culture. ODNs to 4 sites produced a 70% to 80% reduction. In contrast, most sequences targeted between accessible sites were ineffective. When injected into the brains of rats, ODNs targeted to accessible sites reduced AT(1) (by 65%) but not AT(1) receptor levels. Additionally, AT(1) receptor function as measured by agonist-induced water intake, was significantly attenuated in these rats. ODNs directed between accessible sites were ineffective at suppressing water intake, RNA mapping can be applied to any RNA target to facilitate selection of multiple, active antisense sequences for cell culture and in vivo experiments.
引用
收藏
页码:59 / 63
页数:5
相关论文
共 21 条
[1]  
Agrawal S., 1996, ANTISENSE THERAPEUTI
[2]  
Akhtar S., 1995, DELIVERY STRATEGIES
[3]  
Birikh KR, 1997, RNA, V3, P429
[4]   CHARACTERIZATION OF ANGIOTENSIN AT1A-RECEPTOR ISOFORM BY ITS LIGAND-BINDING SIGNATURE [J].
CHIU, AT ;
DUNSCOMB, JH ;
MCCALL, DE ;
BENFIELD, P ;
BAUBONIS, W ;
SAUER, B .
REGULATORY PEPTIDES, 1993, 44 (02) :141-147
[5]   Altered mRNA splicing and inhibition of human E-selectin expression by an antisense oligonucleotide in human umbilical vein endothelial cells [J].
Condon, TP ;
Bennett, CF .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) :30398-30403
[6]   KINETIC CHARACTERISTICS OF ESCHERICHIA-COLI RNASE H1 - CLEAVAGE OF VARIOUS ANTISENSE OLIGONUCLEOTIDE-RNA DUPLEXES [J].
CROOKE, ST ;
LEMONIDIS, KM ;
NEILSON, L ;
GRIFFEY, R ;
LESNIK, EA ;
MONIA, BP .
BIOCHEMICAL JOURNAL, 1995, 312 :599-608
[7]  
DEAN NM, 1994, J BIOL CHEM, V269, P16416
[8]   Facilitating oligonucleotide delivery: Helping antisense deliver on its promise - Commentary [J].
Gewirtz, AM ;
Stein, CA ;
Glazer, PM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (08) :3161-3163
[9]   DETECTION OF RIBONUCLEASE H-GENERATED MESSENGER-RNA FRAGMENTS IN HUMAN LEUKEMIA-CELLS FOLLOWING REVERSIBLE MEMBRANE PERMEABILIZATION IN THE PRESENCE OF ANTISENSE OLIGODEOXYNUCLEOTIDES [J].
GILES, RV ;
SPILLER, DG ;
TIDD, DM .
ANTISENSE RESEARCH AND DEVELOPMENT, 1995, 5 (01) :23-31
[10]   Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries [J].
Ho, SP ;
Britton, DHO ;
Stone, BA ;
Behrens, DL ;
Leffet, LM ;
Hobbs, FW ;
Miller, JA ;
Trainor, GL .
NUCLEIC ACIDS RESEARCH, 1996, 24 (10) :1901-1907